Skip to main content
Clinical Trials/ACTRN12622000337774
ACTRN12622000337774
Recruiting
未知

The wellderly study: effects of exercise on bone remodelling markers in middle-aged and older adults populations

Victoria University0 sites40 target enrollmentFebruary 24, 2022

Overview

Phase
未知
Intervention
Not specified
Conditions
Sarcopenia
Sponsor
Victoria University
Enrollment
40
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 24, 2022
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Males and females aged \>45years or older. Postmenopausal Females will be required to be a minimum of 12 months post menopause.

Exclusion Criteria

  • Potential participants will be excluded from the study if they:
  • have been recently diagnosed (less than 14 days) with COVID\-19, have been identified as a close\-contact of someone with COVID\-19, or have signs or symptoms suggestive of COVID\-19\. Once the individual has been cleared of COVID\-19, they will be allowed to participate in the study. This is to be determined by your medical doctor, and a letter of approval will need to be provided. All participants will be phone screened for these criteria 24 hours prior to each of their in\-person visits (see appendix 4\). They will also complete the form again on arrival.
  • have had any fractures in the previous 3 months, or have commenced antiresorptive medication or any other new osteoporotic treatment within the last three months.
  • have diabetes mellitus or are taking hypoglycaemic medications
  • have any blood or marrow disorders
  • have any bone malignancies or tumours
  • are taking warfarin or vitamin K supplementation or restriction
  • have a body mass index equal to or greater than 40kg/m2
  • are professionally active (compete at a high level: national or international sporting competitions)
  • are a current smoker, or have ceased smoking in the last 12 months

Outcomes

Primary Outcomes

Not specified

Similar Trials